Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$9.44M Sell
369,011
-265,552
-42% -$5.95M 1.09% 32
2015
Q4
$12.6M Buy
634,563
+141,833
+29% +$2.87M 1.3% 29
2015
Q3
$10.4M Sell
492,730
-301,619
-38% -$6.78M 0.97% 51
2015
Q2
$17.8M Sell
794,349
-27,550
-3% -$660K 1.35% 21
2015
Q1
$19.7M Sell
821,899
-412,478
-33% -$10.2M 1.41% 25
2014
Q4
$32.6M Buy
1,234,377
+26,638
+2% +$684K 2.13% 6
2014
Q3
$29.4M Buy
1,207,739
+213,104
+21% +$4.99M 1.63% 11
2014
Q2
$25.9M Sell
994,635
-140,200
-12% -$3.58M 1.35% 21
2014
Q1
$27.2M Buy
1,134,835
+33,199
+3% +$699K 1.48% 12
2013
Q4
$21.5M Buy
1,101,636
+364,520
+49% +$7.34M 1.24% 20
2013
Q3
$15.6M Buy
737,116
+105,150
+17% +$2.3M 0.93% 50
2013
Q2
$13.9M Buy
+631,966
New +$15.3M 0.99% 54

Other funds holding EXC

Killen Group's EXC Position: Q1 2016 in Review

Killen Group reduced its Exelon (EXC) stake by 42% in Q1 2016, selling an estimated $5.95M and leaving 369,011 shares worth $9.44M. The position accounts for 1.09% of the portfolio, ranked #32.

Killen Group first reported a position in EXC in Q2 2013 and has held it in 12 quarters since. The position peaked at $32.6M in Q4 2014. 764 funds tracked by Wall St. Rank hold EXC as of Q1 2016.

  • Killen Group held 369,011 shares of Exelon worth $9.44M as of Q1 2016.
  • Killen Group sold 265,552 Exelon shares in Q1 2016, an estimated $5.95M.
  • Exelon made up 1.09% of Killen Group's portfolio in Q1 2016, its #32 holding.
  • Killen Group first reported a position in Exelon in Q2 2013 and has held it in 12 quarters since.
  • Killen Group's Exelon position peaked at $32.6M in Q4 2014.
  • 764 funds tracked by Wall St. Rank held Exelon as of Q1 2016.

Based on Killen Group's 13F filing for Q1 2016, filed 27 Apr 2016.